Literature DB >> 18574357

Efficacy of opioids for chronic pain: a review of the evidence.

Jane C Ballantyne1, Naomi S Shin.   

Abstract

Opioid therapy for chronic pain has been popularized over the past few decades, and a concern has arisen that the analgesic efficacy of opioids is not always maintained over prolonged courses of treatment despite dose escalation and stable pain. Considering the potentially serious adverse effects of opioids, the idea that pain relief could diminish over time may have a significant impact on the decision to embark on this therapy, especially in vulnerable individuals. Possible loss of analgesic efficacy is especially concerning, considering that dependence may make it hard to withdraw opioid therapy even in the face of poor analgesia. This article first reviews the evidence on opioid efficacy when used for the treatment of chronic pain, and concludes that existing evidence suggests that analgesic efficacy, although initially good, is not always sustained during continuous and long-term opioid therapy (months to years). The theoretical basis for loss of analgesic efficacy over time is then examined. Mechanisms for loss of analgesic efficacy proposed are pharmacologic tolerance, opioid-induced hyperalgesia, subtle and intermittent withdrawal, and a number of psychologic factors including loss of the placebo component.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18574357     DOI: 10.1097/AJP.0b013e31816b2f26

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  100 in total

1.  Anxiety, depression, and opioid misuse among adults with chronic pain: the role of emotion dysregulation.

Authors:  Andrew H Rogers; Michael F Orr; Justin M Shepherd; Jafar Bakhshaie; Joseph W Ditre; Julia D Buckner; Michael J Zvolensky
Journal:  J Behav Med       Date:  2020-06-27

Review 2.  Diabetic Polyneuropathy - Advances in Diagnosis and Intervention Strategies.

Authors:  Solomon Tesfaye; Gordon Sloan
Journal:  Eur Endocrinol       Date:  2020-04-17

3.  Structural basis for μ-opioid receptor binding and activation.

Authors:  Adrian W R Serohijos; Shuangye Yin; Feng Ding; Josee Gauthier; Dustin G Gibson; William Maixner; Nikolay V Dokholyan; Luda Diatchenko
Journal:  Structure       Date:  2011-11-09       Impact factor: 5.006

Review 4.  [Do opioids induce hyperalgesia?].

Authors:  C Zöllner
Journal:  Anaesthesist       Date:  2010-11       Impact factor: 1.041

5.  Interchangeability, Safety and Efficacy of Modified-Release Drug Formulations in the USA: The Case of Opioid and Other Nervous System Drugs.

Authors:  Enrique Seoane-Vazquez; Rosa Rodriguez-Monguio; Richard Hansen
Journal:  Clin Drug Investig       Date:  2016-04       Impact factor: 2.859

Review 6.  Pain and Psychology-A Reciprocal Relationship.

Authors:  Nalini Vadivelu; Alice M Kai; Gopal Kodumudi; Karine Babayan; Manuel Fontes; Matthew M Burg
Journal:  Ochsner J       Date:  2017

7.  Race and Gender Are Associated with Opioid Dose Reduction Among Patients on Chronic Opioid Therapy.

Authors:  Michele Buonora; Hector R Perez; Moonseong Heo; Chinazo O Cunningham; Joanna L Starrels
Journal:  Pain Med       Date:  2019-08-01       Impact factor: 3.750

Review 8.  μ-Opioid receptor 6-transmembrane isoform: A potential therapeutic target for new effective opioids.

Authors:  Marino Convertino; Alexander Samoshkin; Josee Gauthier; Michael S Gold; William Maixner; Nikolay V Dokholyan; Luda Diatchenko
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2014-12-06       Impact factor: 5.067

Review 9.  [Options for pain therapy of urologic chronic pelvic pain syndrome (UCPPS)].

Authors:  O Moormann
Journal:  Urologe A       Date:  2009-10       Impact factor: 0.639

10.  Lack of correlation between opioid dose adjustment and pain score change in a group of chronic pain patients.

Authors:  Lucy Chen; Trang Vo; Lindsey Seefeld; Charlene Malarick; Mary Houghton; Shihab Ahmed; Yi Zhang; Abigail Cohen; Cynthia Retamozo; Kristen St Hilaire; Vivian Zhang; Jianren Mao
Journal:  J Pain       Date:  2013-02-26       Impact factor: 5.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.